Details for New Drug Application (NDA): 021861
✉ Email this page to a colleague
The generic ingredient in PATANASE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 021861
Tradename: | PATANASE |
Applicant: | Novartis |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 021861
Suppliers and Packaging for NDA: 021861
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861 | NDA AUTHORIZED GENERIC | Sandoz Inc | 61314-320 | 61314-320-01 | 1 BOTTLE in 1 CARTON (61314-320-01) / 30500 uL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.665MG/SPRAY | ||||
Approval Date: | Apr 15, 2008 | TE: | RLD: | Yes |
Expired US Patents for NDA 021861
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription